Atria Wealth Solutions, Inc. Simulations Plus, Inc. Transaction History

Atria Wealth Solutions, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$38.46 - $50.95 $86,611 - $114,739	-2,252 Reduced 17.45%	10,654 $517,000
Q1 2024 May 13, 2024	SELL	$37.48 - $44.74 $29,684 - $35,434	-792 Reduced 5.78%	12,906 $531,000
Q4 2023 Feb 02, 2024	SELL	$33.36 - $45.71 $22,184 - $30,397	-665 Reduced 4.63%	13,698 $612,000
Q3 2023 Nov 08, 2023	SELL	$40.03 - $51.51 $102,356 - $131,711	-2,557 Reduced 15.11%	14,363 $598,000
Q2 2023 Aug 03, 2023	BUY	$40.45 - $48.0 $51,533 - $61,152	1,274 Added 8.14%	16,920 $733,000
Q1 2023 Jun 14, 2023	SELL	$34.96 - $43.94 $44,539 - $55,979	-1,274 Reduced 7.53%	15,646 $687,000
Q1 2023 May 10, 2023	BUY	$34.96 - $43.94 $44,539 - $55,979	1,274 Added 8.14%	16,920 $743,000
Q4 2022 Aug 30, 2023	SELL	$36.55 - $51.15 $46,564 - $65,165	-1,274 Reduced 7.53%	15,646 $572,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $747,096 - $1.05 Million	15,646 New	15,646 $759,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $622M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.